<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A-2
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 7, 1999
------------
CHROMATICS COLOR SCIENCES INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
New York
--------
(State or other jurisdiction of incorporation)
0-21168 13-3253392
---------------------------------------------------
(Commission File Number) (IRS Employer Identification Number)
5 East 80th Street, New York, New York 10021
--------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (212) 717-6544
-----------------------------------------------------------------
Page 1 of 3 pages
<PAGE>
EXPLANATORY NOTE
This Current Report on Form 8-K/A-2 amends and
restates in its entirety the text of Item 5
of the Company's Current Report on Form 8-K
filed with the Securities and Exchange Commission on June 18, 1999.
ITEM 5. OTHER EVENTS
On June 7, 1999, Chromatics Color Sciences International Inc. (the
"Company") executed a renewable, five-year agreement with Datex-Ohmeda, Inc. and
its Ohmeda medical division ("DO") pursuant to which the Company appointed DO as
the exclusive distributor in the United States of the Company's
Colormate(Registered Trademark) TLc-BiliTest(Registered Trademark) System for
noninvasive monitoring of bilirubin infant jaundice in the hospital market, the
non-consumer home healthcare market (in which the test is administered solely by
a healthcare professional), the pediatrician, office market and clinics within
all such markets. The agreement also applies to the Company's
TLc-Lensette(Registered Trademark) disposable standard that is used to calibrate
each measurement taken by the Colormate(Registered Trademark)
TLc-BiliTest(Registered Trademark) System. The terms of the agreement provide
for minimum purchases of Colormate(Registered Trademark) System units and
TLc-Lensette(Registered Trademark) disposable color-calibration and verification
standards for the term of the agreement. There are no financial penalties for
failure to meet these minimum levels. However, the Company has the option to
terminate the agreement if these minimums are not met. The Company will sell its
products to DO in accordance with the minimum sale prices set forth in the
agreement and will also share in the sales revenues for such products. In
addition, the agreement grants DO negotiation rights for international marketing
and distribution of the Company's monitoring system for the potential retail
market and consumer home healthcare market where the test is not administered by
a healthcare professional, subject to further required regulatory clearances for
commercial use.
Pursuant to Item 601(b)(10) of Regulation S-K promulgated under the
Securities Act of 1933, the Company is filing the agreement as Exhibit 10.1 to
the report.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CHROMATICS COLOR SCIENCES
INTERNATIONAL, INC.
By: /s/ Darby S. Macfarlane
--------------------------
Name: Darby S. Macfarlane
Title: Chief Executive Officer
Date: January 20, 2000
